Libtayo Injection
Product Images NDC 61755-008

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Libtayo (NDC 61755-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (350 mg/7 mL Vial Carton)

This appears to be a table or chart showing the Probability of Survival for a treatment called "Cemiplimab" compared to "Chemotherapy". The chart shows the number of subjects at risk over the span of 32 months. However, without additional context it is difficult to provide a more specific description or analysis.*

FDA Label Image

Libtayo 02

This text appears to be a mixture of product information for a medical injection called "IBTAYO" and some ingredient information. The injection contains 350mg of 'cemiplimab-rwic' per 7ml of solution, and is intended for intravenous infusion after dilution. It appears to come in a single-dose vial and the medication guide should be enclosed for each patient. The dosage and administration information are not clearly stated, so it is best to seek medical advice and follow the standard of potency. There are also ingredients mentioned such as polysorbate 80, water, and sucrose. The rest of the text is hard to understand, and some sections have blurry text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.